Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A, Isoform 1-TAT

SKU: orb1952536

Description

Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A, Isoform 1-TAT

Research Area

Pharmacology & Drug Discovery

Key Properties

• Expression System: Escherichia coli
• Biological Activity: Data is not available.
• Molecular Weight: Approximately18.0 kDa, a single non-glycosylated polypeptide chain containing 167 amino acids.
• Protein Sequence: EPAAGSSMEP SADWLATAAA RGRVEEVRAL LEAGALPNAP NSYGRRPIQV MMMGSARVAE LLLLHGAEPN CADPATLTRP VHDAAREGFL DTLVVLHRAG ARLDVRDAWG RLPVDLAEEL GHRDVARYLR AAAGGTRGSN HARIDAAEGP SDIPDGYGRK KRRQRRR
• Purity: > 95 % by SDS-PAGE and HPLC analyses.
• Endotoxins: Less than 1 EU/ug of rHuP16-INK4a-TAT as determined by LAL method.

Storage & Handling

• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.- 1 month, 2 to 8 °C under sterile conditions after reconstitution.- 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Form/Appearance: Lyophilized from a 0.2 μm filtered concentrated solution in 2 x PBS, pH 7.0.
• Expiration Date: 6 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

CDK4I, MTS-1, p16INK4A